Literature DB >> 17897729

Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China.

Guimei He1, Jian Qiao, Changgui Dong, Cheng He, Lihong Zhao, Yong Tian.   

Abstract

We tested the amantadine-resistance among avian influenza A (H5N1) viruses isolated from chicken in Hebei Province of Northern China from 2001 to 2005, and investigated the amantadine use in this area. Plague reduction assay in MDCK cells showed that 83.3% isolates (5/6) were amantadine-resistant strains. The M2 sequence analysis revealed that four of five resistant isolates contained the point mutations (Ser to Asn) at position 31 that could confer resistance to amantadine. These results indicated that the incidence of amantadine-resistant viruses isolated in Northern China was particularly high. In the investigation of amantadine use, we found that amantadine was used extensively in poultry farms in this area, which maybe was one of reasons of the high amantadine-resistance incidence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17897729     DOI: 10.1016/j.antiviral.2007.08.007

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  47 in total

1.  Emergence of amantadine-resistant avian influenza H5N1 virus in India.

Authors:  C Tosh; H V Murugkar; S Nagarajan; S Tripathi; M Katare; R Jain; R Khandia; Z Syed; P Behera; S Patil; D D Kulkarni; S C Dubey
Journal:  Virus Genes       Date:  2010-10-16       Impact factor: 2.332

2.  Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine.

Authors:  John H Beigel; Jocelyn Voell; Chiung-yu Huang; Peter D Burbelo; H Clifford Lane
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

3.  [Influenza : clinical symptoms, diagnostics and therapy].

Authors:  G G U Rohde
Journal:  Internist (Berl)       Date:  2011-09       Impact factor: 0.743

4.  Avian influenza from an ecohealth perspective.

Authors:  Les Simms; Martyn Jeggo
Journal:  Ecohealth       Date:  2014-04-24       Impact factor: 3.184

5.  Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic.

Authors:  David A Boltz; Bounlom Douangngeun; Phouvong Phommachanh; Settha Sinthasak; Ricarda Mondry; Caroline Obert; Patrick Seiler; Rachael Keating; Yasuo Suzuki; Hiroaki Hiramatsu; Elena A Govorkova; Robert G Webster
Journal:  J Gen Virol       Date:  2009-12-16       Impact factor: 3.891

6.  Antiviral resistance among highly pathogenic influenza A (H5N1) viruses isolated worldwide in 2002-2012 shows need for continued monitoring.

Authors:  Elena A Govorkova; Tatiana Baranovich; Patrick Seiler; Jianling Armstrong; Andrew Burnham; Yi Guan; Malik Peiris; Richard J Webby; Robert G Webster
Journal:  Antiviral Res       Date:  2013-02-28       Impact factor: 5.970

7.  T-705 (favipiravir) activity against lethal H5N1 influenza A viruses.

Authors:  Maki Kiso; Kazumi Takahashi; Yuko Sakai-Tagawa; Kyoko Shinya; Saori Sakabe; Quynh Mai Le; Makoto Ozawa; Yousuke Furuta; Yoshihiro Kawaoka
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

8.  5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication.

Authors:  Priya Ranjan; Lakshmi Jayashankar; Varough Deyde; Hui Zeng; William G Davis; Melissa B Pearce; John B Bowzard; Mary A Hoelscher; Victoria Jeisy-Scott; Mayim E Wiens; Shivaprakash Gangappa; Larisa Gubareva; Adolfo García-Sastre; Jacqueline M Katz; Terrence M Tumpey; Takashi Fujita; Suryaprakash Sambhara
Journal:  Virol J       Date:  2010-05-21       Impact factor: 4.099

9.  Rapid and specific detection of amantadine-resistant influenza A viruses with a Ser31Asn mutation by the cycling probe method.

Authors:  Yasushi Suzuki; Reiko Saito; Hassan Zaraket; Clyde Dapat; Isolde Caperig-Dapat; Hiroshi Suzuki
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

10.  New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets.

Authors:  Robert H E Friesen; Wouter Koudstaal; Martin H Koldijk; Gerrit Jan Weverling; Just P J Brakenhoff; Peter J Lenting; Koert J Stittelaar; Albert D M E Osterhaus; Ronald Kompier; Jaap Goudsmit
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.